ArticleEnvironmental analysis, health and toxicology2025
Earthworm gut microbiota: A novel biocatalyst for the sustainable degradation of carbendazim in Agro-ecosystems.
Article in Environmental analysis, health and toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Carbendazim is a widely used fungicide in agriculture, poses significant environmental risks due to its persistence in terrestrial and aquatic ecosystems. To investigate the potential for bioremediation of carbendazim, three bacterial strains, Bacillus aureus PPH1, Bacillus paralicheniformis PPH2, and Bacillus stercoris PPH3, were isolated from the gastrointestinal tract of Glyphidrilus sp. earthworms, a common inhabitant of paddy fields. In a controlled laboratory experiment, all the strains were incubated with 100 mg/L carbendazim in minimal salt medium for five days. The HPLC analysis revealed that B. aureus PPH1, B. paralicheniformis PPH2, and B. stercoris PPH3 degraded 87.18%, 89.66%, and 91.21% of carbendazim, respectively. LC-MS/MS analysis subsequently confirmed the existence of 2-aminobenzimidazole and 2-hydroxybenzimidazole as major metabolites, suggesting a potential biotransformation pathway for carbendazim degradation. This investigation offers novel insights into the biodegradation mechanisms of carbendazim facilitated by gut bacteria of paddy field earthworms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.